Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 6 sources · 3 days · First seen 7 days ago · Last updated 4 days ago

Corporate stock analyst rating updates

Overview

Market analysts have issued various rating updates and price target adjustments across the technology, biopharmaceutical, and industrial sectors.

In the biopharmaceutical and technology sectors, BTIG Research reaffirmed ‘buy’ ratings for Consensus Cloud Solutions, Cullinan Therapeutics, and Nektar Therapeutics, with Nektar receiving a price target of $178.00. Trimble also received a rating upgrade from ‘Hold’ to ‘Buy’ from Wall Street Zen following strong second-quarter revenue.

Subsequent updates from major financial institutions showed mixed results for large corporations. Jefferies lowered price targets for Adidas and Munich Re while maintaining ‘Buy’ and ‘Hold’ ratings, respectively. Conversely, Monness Crespi raised the price target for Meta Platforms to 830 USD, citing its AI strategy. Additionally, JPMorgan maintained an ‘Overweight’ rating for Siemens AG and a ‘Neutral’ rating for Thyssenkrupp.

Entities

Thyssenkrupp · Philip Kett · Siemens AG · Meta Platforms · BTIG Research

Timeline

4 days ago

[BUSINESS] 3 sources
Major corporations see shifts in analyst ratings and price targets
Financial analysts have issued updated ratings and price targets for several major companies, including Meta Platforms, Adidas, Siemens, Munich Re, and Thyssenkrupp.
7 days ago

[BUSINESS] 3 sources
Market analysts issue new ratings for various technology and biotech firms
Market analysts have issued new ratings and price targets for several companies, including Trimble, Nektar Therapeutics, and Consensus Cloud Solutions, across the tech and biotech sectors.

Sources

ad-hoc-news.de · finanznachrichten.de · it-boltwise.de · m.aktiencheck.de · seekingalpha.com · stocknews.com